Gazprom Neft (SIBN)
Moscow Exchange · Russia · prices in RUB · close of 19 Oct 2026
Key indicators
| Last close | RUB 570.00 |
|---|---|
| 52-week range | 365.00 – 637.50 |
| Return, 1 month / 3 months | +5.9% / +39.2% |
| Return, 1 year / 3 years | +16.6% / −20.8% |
| Trend | Uptrend |
| RSI (14) | 53 |
| Volatility (1 year) | 31.4% |
| Worst drawdown (1 year) | -34.7% |
| Average daily value traded | 947.88M RUB |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Gazprom Neft is a Russian oil and gas company based in Saint Petersburg. It explores for and produces crude oil and natural gas, refines crude oil at its own refineries, and sells petroleum products such as gasoline, diesel and lubricants. Its customers include wholesale buyers, industrial users and motorists who fill up at its branded filling stations across Russia and in several neighbouring countries. The company also supplies aviation fuel and bitumen for road construction.
Gazprom Neft trades under the code SIBN on the Moscow Exchange in Russia, with its price quoted in Russian rubles (RUB). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Gazprom Neft (SIBN) trades on the Moscow Exchange in Russia. It last closed at RUB 570.00 on 19 October 2026.
Its price-based Market X-Ray is 88 out of 100 (a strong price profile), ranking 1 of 250 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 16.6% and over the last three months it rose 39.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Moscow Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 94 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 13.3% | ||
| From 52-week high | -9.0% | ||
| Momentum | 91 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 39.2% | ||
| 6-month return | 9.0% | ||
| 12-month return, skipping the last month | 10.1% | ||
| Stability (higher is calmer) | 77 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 31.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -34.7% | ||
| Liquidity | 92 · Strong | Trades actively. | |
| Average daily value traded | 947.88M RUB | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −9.0% |
|---|---|
| 1 month | +5.9% |
| 3 months | +39.2% |
| 6 months | +9.0% |
| 1 year | +16.6% |
| 3 years | −20.8% |
| 5 years | +74.9% |
Signals
| 50-day / 200-day average | 535.39 / 503.31 |
|---|---|
| Golden / death cross (60 days) | Golden, 14 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 20.95 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 Jul 2024 | RUB 20.3500 |
| 30 Dec 2023 | RUB 55.5100 |
| 10 Jul 2023 | RUB 12.1600 |
| 25 Jun 2023 | RUB 20.2600 |
| 30 Dec 2022 | RUB 69.7800 |
| 8 Jul 2022 | RUB 16.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Moscow Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.